Orbital metastases are relatively uncommon, but some primary tumours do have a predilection to metastasise to the orbit.
This article concerns itself with extraocular metastases, rather than intraocular tumours or direct extension of tumours from neighbouring regions. For a discussion of intraocular metastases please refer to uveal metastases.
Extraocular orbital metastases are uncommon, accounting for 2-11% of all orbital neoplasms, and significantly less common than uveal metastases, which outnumber orbital metastases by 8 to 1 1,3,6. The demographics of affected patients reflect the demographics of the primary tumours (see below).
In general, patients with metastatic disease do not develop orbital metastases, being identified clinically in <1% of cases. Prevalence is much higher in autopsy series, reflecting the high prevalence of asymptomatic orbital deposits 7.
In ~40% of patients who are symptomatic from orbital metastases (except for breast cancer metastases), orbital symptoms occur well before local symptoms form the primary tumour manifest, and as such are the first indication of advanced malignancy 1,3,6.
Unlike primary orbital tumours which most frequently present with proptosis and/or visual loss, orbital metastases most commonly present with diplopia 1. Pain is also frequently present.
Enophthalmos due to infiltration and desmoplasia is most frequently encountered with breast carcinoma metastases, although it may also be occasionally seen in metastases from gastrointestinal tract adenocarcinoma 4.
Diagnosis is often known and widespread metastatic disease offers easier targets for biopsy. In cases where orbital metastases are isolated, biopsy may be required to establish the diagnosis. This is usually performed as an open biopsy, to allow for adequate haemostasis 1,3.
Common tumours to metastasize to the orbit include 1-6
- breast cancer
- bronchogenic cancer
- prostate cancer
- gastrointestinal adenocarcinoma
- thyroid carcinoma
- renal cell carcinoma
- Ewing sarcoma
- Wilms tumour
In contrast to uveal metastases which can be bilateral (up to 25%), extraocular orbital metastases are usually unilateral (with the exception of neuroblastoma) 7, and only infrequently primarily involve the extraocular muscles (with the exception of melanoma) 7, although secondary involvement as the metastasis grows is common 1-2. Thyroid and prostate metastases are frequently located in the bony margins of the orbit 7.
The superior lateral extraconal quadrant is most frequently involved although all parts of the orbit may be the site of metastatic deposit.
CT appearances are variable. In most instances soft tissue attenuating material is identified, located in the extraconal compartment 6. The morphology is variable, ranging from well-defined rounded lesions to diffusely infiltrating lesions 5.
In general enhancement is present. Bony destruction may also sometimes be seen, and careful assessment of the remainder of the scan essential in identifying additional deposits.
MRI appearances are similar to CT, but the greater contrast resolution of MRI makes it invaluable in the assessment of orbital masses.
Fat suppressed T2 and post-contrast T1 weighted images, with thin slice thickness and a reduced FOV is ideal, and should include the cavernous sinuses.
- T1: isointense to muscle 8
- T2: hyperintense to muscle, hypointense to fat
- T1 C+ (GAD): enhancement present but variable
Treatment and prognosis
Treatment is primarily with radiotherapy, typically with a total dose of 30-40Gy 1. Depending on the tumour histology chemotherapy may also be useful. Surgery is usually limited to patients with isolated orbital involvement without an identifiable (or a previously treated) primary.
Unfortunately, the discovery of orbital metastases usually indicates advanced and widespread metastatic disease and prognosis is dismal with the majority of patients succumbing to their illness within a year (average time from diagnosis to death is 4 months) 7.
- primary orbital malignancy
- extraocular extension of intraocular tumour
- tumours of the optic nerve
- orbital vascular lesion
- orbital infection
- thyroid associated orbitopathy
- inflammatory/granulomatous conditions
- 1. Char DH, Miller T, Kroll S. Orbital metastases: diagnosis and course. Br J Ophthalmol. 1997;81 (5): 386-90. doi:10.1136/bjo.81.5.386 [free text at pubmed] [pubmed citation]
- 2. Ashton N, Morgan G. Discrete carcinomatous metastases in the extraocular muscles. Br J Ophthalmol. 1974;58 (2): 112-7. Br J Ophthalmol (link) [free text at pubmed] [pubmed citation]
- 3. Green S, Som PM, Lavagnini PG. Bilateral orbital metastases from prostate carcinoma: case presentation and CT findings. AJNR Am J Neuroradiol. 1995;16 (2): 417-9. AJNR Am J Neuroradiol (abstract) [pubmed citation]
- 4. de Keyser J, Bruyland M, de Greve J et-al. Enophthalmos as a rare manifestation of metastatic orbital involvement. Postgrad Med J. 1985;61 (712): 149-52. doi:10.1136/pgmj.61.712.149 [free text at pubmed] [pubmed citation]
- 5. Head and neck imaging. Ed. by Peter M. Som, Hugh D. Curtin. St Louis (Mo.) : Mosby-Year Book, 2003. ISBN:0323009425 (find it at amazon.com)
- 6. Imaging of Orbital and Visual Pathway Pathology. Wibke S. Müller-Forell (Editor), N. Pfeiffer (Preface), K. Sartor (Foreword), E. Boltshauser (Contributor), S. Kollias (Contributor), W. Lieb (Contributor), E. Martin (Contributor), W.S. Müller-Forell (Contributor), S. Pitz (Contributor), U. Schwarz (Contributor), W. Wichmann (Contributor). Springer ISBN:3540279881 (find it at amazon.com)
- 7. Orbital tumors. Zeynel A. Karcioglu; with 482 illustrations, 276 in color. New York : Springer, c2005. ISBN:038721321X (find it at amazon.com)
- 8. Head and neck imaging. Ulrich Moedder. [et al.]; [translator, Terry Telger]. Stuttgart; Thieme, c2008. ISBN:3131440813 (find it at amazon.com)